CSL Vifor
Organisation
Named in competing interests
Achieved systolic blood pressure and cardiovascular outcomes in advanced chronic kidney disease
Fees or honoraria, 31 Aug 2026
Consulting or advice, Fees or honoraria, Grants or research support, 26 Aug 2026
Burden of chronic kidney disease and outcomes following hospitalisation for heart failure
Consulting or advice, Board or leadership role, 25 Aug 2026
Fees or honoraria, Grants or research support, 21 Aug 2026
Impact of Empagliflozin on Serum Calcium and Phosphate in Heart Failure
Consulting or advice, 7 Aug 2026
More than Glucose Elimination: Additional Benefits of SGLT2 Inhibitors in Glomerular Diseases
Consulting or advice, Fees or honoraria, Grants or research support, 15 Feb 2026
Sources: pubmed.ncbi.nlm.nih.gov
Papers
ADA Scientific Sessions 2025 abstract, 13 Jun 2025